Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Yuxingcao Mixture
- Development stage
- Unknown
- Lead developer
- Nanjing University of Chinese Medicine
- Administration
- Oral
01
Overview
Compound Yuxingcao Mixture (also known as Fufang Yuxingcao Heji) is a traditional Chinese medicine (TCM) oral liquid formulation widely used in China for its heat-clearing, detoxifying, and anti-inflammatory properties. It is composed of five herbal ingredients: Houttuyniae Herba (Yuxingcao), Scutellariae Radix (Huangqin), Isatidis Radix (Banlangen), Forsythiae Fructus (Lianqiao), and Lonicerae Japonicae Flos (Jinyinhua). The mixture is primarily indicated for the treatment of sore throat, acute pharyngitis, and tonsillitis caused by exogenous wind-heat. During the COVID-19 pandemic, it was investigated for its potential therapeutic benefits in patients with COVID-19, and its mechanisms of action have been studied via network pharmacology, showing potential immunomodulatory and antiviral activities.
- Brand names
- JindiKefule
- Other names
- CYMFufang Yuxingcao HejiFufang Yuxingcao Mixture
02
Targets
IFNG (Interferon gamma)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)JUN (Transcription factor Jun)MAPK14 (p38 mitogen-activated protein kinase alpha)MMP9 (Matrix metalloproteinase-9)
Beyond the preview
Go deeper on Compound Yuxingcao Mixture.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Yuxingcao Mixture.